Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
6 this month

Showing 81–100 of 17,529 recalls

January 20, 2026· ACME UNITED CORPORATION

Recalled Item: Children's Healthcare of Atlanta

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 16, 2026· McKesson

Recalled Item: UDENYCA

The Issue: Temperature Abuse. 116 cartons with specific serial numbers

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 16, 2026· Specialty Process Labs LLC

Recalled Item: Thyroid

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 15, 2026· Greenstone Llc

Recalled Item: methylprednisolone tablets

The Issue: Labeling: Not Elsewhere Classified. Incorrect orientation of the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 14, 2026· Amerisource Health Services LLC

Recalled Item: Oxycodone Hydrochloride Tablets

The Issue: Defective container: Multiple customer complaints received for card

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 10, 2026· Graviti Pharmaceuticals Private Limited

Recalled Item: Furosemide Tablets

The Issue: Presence of Foreign Substance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 6, 2026· Encon Safety Products Co

Recalled Item: AQ 120 GFEW

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 2, 2026· Cipla USA, Inc.

Recalled Item: Lanreotide Injection

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· Wizcure Pharmaa Private Limited

Recalled Item: BioGlo Fluorescein Sodium Ophthalmic Strips USP

The Issue: Lack of Assurance of Sterility: Products have not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· Wizcure Pharmaa Private Limited

Recalled Item: Bio Glo Fluorescein Sodium Ophthalmic Strips USP

The Issue: Lack of Assurance of Sterility: Products have not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· Wizcure Pharmaa Private Limited

Recalled Item: Vista Tears Polyethylene Glycol 400 0.4% w/v

The Issue: Lack of Assurance of Sterility: Products have not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· Wizcure Pharmaa Private Limited

Recalled Item: Vista Gel Hypromellose USP 0.3% w/v

The Issue: Lack of Assurance of Sterility: Products have not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· Wizcure Pharmaa Private Limited

Recalled Item: Vista Gonio Eye Lubricant

The Issue: Lack of Assurance of Sterility: Products have not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· Wizcure Pharmaa Private Limited

Recalled Item: Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced

The Issue: Lack of Assurance of Sterility: Products have not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· Wizcure Pharmaa Private Limited

Recalled Item: CHNaO Fluorescein Sodium Ophthalmic Strips

The Issue: Lack of Assurance of Sterility: Products have not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· Alvogen, Inc

Recalled Item: Levothyroxine Sodium Tablets

The Issue: Product Mix-Up: A single bottle of this lot

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 31, 2025· AvKARE

Recalled Item: Rosuvastatin Tablets

The Issue: Out of specification for dissolution

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 30, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Icosapent Ethyl capsules

The Issue: Subpotent Drug: Due oxidation caused by leakage of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 30, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Fluocinolone Acetonide Solution Topical Solution USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
December 30, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Ondansetron Orally Disintegrating Tablets

The Issue: Defective container: Preferred Pharmaceuticals received a letter from

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund